Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1993 1
1994 6
1995 3
1997 4
1998 7
1999 15
2000 9
2001 5
2002 7
2003 10
2004 5
2005 6
2006 7
2007 3
2009 1
2010 2
2019 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 10510053

92 results

Results by year

Filters applied: . Clear all
Page 1
Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.
Hamm CW, Heeschen C, Goldmann B, Vahanian A, Adgey J, Miguel CM, Rutsch W, Berger J, Kootstra J, Simoons ML. Hamm CW, et al. N Engl J Med. 1999 May 27;340(21):1623-9. doi: 10.1056/NEJM199905273402103. N Engl J Med. 1999. PMID: 10341274 Free article. Clinical Trial.
Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA.
Lenderink T, Boersma E, Heeschen C, Vahanian A, de Boer MJ, Umans V, van den Brand MJ, Hamm CW, Simoons ML; CAPTURE Investigators. Lenderink T, et al. Eur Heart J. 2003 Jan;24(1):77-85. doi: 10.1016/s0195-668x(02)00322-6. Eur Heart J. 2003. PMID: 12559939 Clinical Trial.
92 results